Molecular radiation biology/oncology

Radiotherapy and Oncology

Volumn 72, Issue 3, 2004, Pages 247-249

  Rodemann, H Peter ^a   Baumann, Michael ^b   Bodis, Stephan ^c   Dikomey, Ekkehard ^d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c State Hospital Aarau   (Switzerland)

^d UNIVERSITY OF HAMBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CETUXIMAB; CYTOKINE; DOUBLE STRANDED DNA; GROWTH FACTOR;

CANCER SURVIVAL; CELL CYCLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL DIFFERENTIATION; CELL INTERACTION; CELL PROLIFERATION; CLINICAL TRIAL; CONFERENCE PAPER; DNA DAMAGE; DNA REPAIR; EXTRACELLULAR MATRIX; HEAD AND NECK CANCER; HUMAN; ONCOLOGY; PHENOTYPE; PRIORITY JOURNAL; RADIOBIOLOGY; RADIOSENSITIVITY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR GROWTH;

RADIATION ONCOLOGY; RADIOBIOLOGY;

EID: 4644356575     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2004.08.001     Document Type: Conference Paper

References (22)

1. J. Barbart-Guirouilh, S. Huck, P. Bertrand, L. Pirzio, and C. Desmaze Impact of the KU pathway on NHEJ-induced genome rearrangements, in mammalian cells Mol Cell 14 2004 611 623
2. M. Baumann, M. Krause, and D. Zips Selective inhibition of the epidermal growth factor tyrosine kinase by BIBX1382BS improves growth delay but not local control after fractionated irradiation in human FaDu squamous cell carcinoma in nude mice Int J Radiat Biol 79 2003 547 559
3. Bonner JA, Harari PM, Giralt JL, et al. Cetuximab (Erbitux TM) prolongs survival in patients with locally advanced squamous cell carcinoma of the head and neck: a phase III study of high dose radiation therapy with and without cetuximab. Oral ASCO presentation 2004, abstract 5507.
4. P.E. Bryant The signal model: a possible explanation for the conversion of DNA double-strand breaks into chromatid breaks Int J Radiat Biol 73 1998 243 251
5. P.E. Bryant, C. Jones, G. Armstrong, M. Frankenberg-Schwager, and D. Frankenberg Induction of chromatid breaks by carbon-K ultra-soft X-rays Rad Res 159 2003 247 250
6. J. Bussink, J.H.A.M. Kaanders, and A.J. van der Kogel Tumor hypoxia at the micro regional level: clinical relevance and predictive value of exogenous and endogenous hypoxic cell markers Radiother Oncol 67 2003 3 15
7. C.N. Coleman Clinical applications of molecular biology in radiation oncology Sem Radiat Oncol 6 1996 245 249
8. C.N. Coleman Of what use is molecular biology to the practising radiation oncologist? Radiother Oncol 46 1998 117 125
9. C.N. Coleman, and R.L. Cumberlin Translational research in radiation oncology Int J Radiat Oncol Biol Phys 49 2001 885 890
10. Z. Horejsi, J. Falck, C.J. Bakkenist, M.B. Kastan, J. Lukas, and J. Bartek Distinct functional domains of Nbs1 modulate the timing and magnitude of ATM activation after low doses of ionizing radiation Oncogene 23 2004 3122 3127
11. F. Kiessling, N. Farhan, and M.P. Lichy Dynamic contrast-enhanced magnetic resonance imaging rapidly indicates vessel regression in human squamous cell carcinomas grown in nude mice caused by VEGF receptor 2 blockage with DC101 Neoplasia 6 2004 213 223
12. M.F.H. Krause, F. Hessel, D. Zips, F. Hilberg, and M. Baumann Adjuvant inhibition of the epidermal growth factor receptor after fractionated irradiation of FaDu human squamous cell carcinoma Radiother Oncol 72 2004 95 101
13. G. Lammering Inhibition of the EGFRvIII mutant receptor by dominant-negative EGFR-CD533 enhances malignant glioma cell radiosensitivity Clin Cancer Res 2004 in press
14. G. Lammering, K. Valerie, and P.S. Lin Radiosensitization of malignant glioma cells through overexpression of dominant-negative epidermal growth factor receptor Clin Cancer Res 7 2001 682 690
15. K. Liang, K. Ang, L. Milas, N. Hunter, and Z. Fan The epidermal growth factor receptor mediates radioresistance Int J Radiat Oncol Biol Phys 57 2003 246 254
16. C. Lukas, F. Melander, and M. Stucki Mdc1 couples DNA double-strand break recognition by Nbs1 with ist H2AX-dependent chromatin retention EMBO J 2004 in press
17. A.C. Riches, P.E. Bryant, and C.M. Steel Chromosomal radiosensitivity in G2-phase lymphocytes identifies breast cancer patients with distinctive tumour characteristics Br J Cancer 85 2001 1157 1161
18. Y. Saintigny, F. Delacote, and G. Vares Characterization of homologous recombination induced by replication inhibition in mammalian cells EMBO J 20 2001 3861 3870
19. R.K. Schmidt-Ullrich, J.N. Contessa, G. Lammering, G. Amorino, and P.S. Lin ERBB receptor tyrosine kinases and cellular radiation responses Oncogene 22 2003 5855 5865
20. G.S. Stewart, B. Wang, C.R. Bignell, A.M.R. Taylor, and S.J. Elledge MDC1 is a mediator of the mammalian DNA damage checkpoint Nature 421 2003 961 966
21. M. Toulany, K. Dittmann, and M. Baumann Inhibition of AKT/protein kinase b but not mitogen activated protein kinase/ERK modulates radiation response by EGFR antagonist Radiother Oncol 67 2003 S20
22. R. Weissleder, and U. Mahmood Molecular imaging Radiology 219 2001 316 333